Literature DB >> 11386679

Topical photodynamic therapy at low fluence rates--theory and practice.

K Langmack1, R Mehta, P Twyman, P Norris.   

Abstract

Photodynamic Therapy (PDT), with topically applied 5-aminolaevulinic acid as the photosensitiser, is an effective treatment for various malignant and pre-malignant skin conditions. Several studies have shown the importance of fluence rate as well as fluence in the efficacy of PDT. We propose a measure of PDT efficacy, Photodynamic Damage Dose (PDD), which uses the product of instantaneous fluence rates, photosensitiser concentrations and oxygen concentrations in its calculation. We derive a qualitative numerical model of PDT and verify it by demonstrating an inverse fluence rate effect, increased efficacy of fractionated PDT, PDT induced hypoxia, and the dependence of photobleaching on fluence rate under certain circumstances. We recommend that fluence, fluence rate and any fractionation regime used should be detailed when reporting a trial as altering any of these has significant effects on PDT efficacy. The model predicts that low fluence rate irradiations should be as effective as high fluence rate irradiations if carried out over the same length of time. To test this we build a light emitting diode-based lamp (fluence rate of 7 mW cm(-2) at 635 nm) and used it to treat 32 superficial basal cell carcinomas on 22 patients (30 min treatment time, fluence 12.6 J cm(-2)). The complete response rate at one year was 84%, which is comparable to that achieved using higher fluence rate sources for similar treatment times. We conclude that this robust, inexpensive light source is effective for topical PDT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386679     DOI: 10.1016/s1011-1344(01)00116-6

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  9 in total

1.  A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.

Authors:  Nathalie C Zeitouni; Ulas Sunar; Daniel J Rohrbach; Anne D Paquette; David A Bellnier; Yi Shi; Gregory Wilding; Thomas H Foster; Barbara W Henderson
Journal:  Dermatol Surg       Date:  2014-12       Impact factor: 3.398

2.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2004-10-26       Impact factor: 3.161

3.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2005       Impact factor: 3.161

4. 

Authors:  C S Betz; A Leunig
Journal:  HNO       Date:  2004-02       Impact factor: 1.284

5.  Influence of laser wavelength on the damage of comb's vasculature by photodynamic therapy--simulation and validation of mathematical models.

Authors:  Naiyan Huang; Gang Cheng; Ying Wang; Jing Zeng; Haixia Qiu; Ying Gu
Journal:  Lasers Med Sci       Date:  2011-02-16       Impact factor: 3.161

6.  Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.

Authors:  William J Cottrell; Anne D Paquette; Kenneth R Keymel; Thomas H Foster; Allan R Oseroff
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

7.  A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.

Authors:  Nathalie C Zeitouni; Anne D Paquette; Joseph P Housel; Yi Shi; Gregory E Wilding; Thomas H Foster; Barbara W Henderson
Journal:  Lasers Surg Med       Date:  2013-02-06       Impact factor: 4.025

Review 8.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Photodynamic inactivation of mammalian viruses and bacteriophages.

Authors:  Liliana Costa; Maria Amparo F Faustino; Maria Graça P M S Neves; Angela Cunha; Adelaide Almeida
Journal:  Viruses       Date:  2012-06-26       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.